Machine Learning-Driven Identification of Serotype-Independent Pneumococcal Vaccine Candidates using samples from Human Infection Challenge Studies
Abstract
Abstract Identifying conserved, immunogenic proteins that confer protection against Streptococcus pneumoniae colonisation could enable development of serotype-independent vaccines. We analysed baseline samples from 86 healthy adults experimentally challenged with pneumococcal serotypes 6B or 15B to investigate whether immune responses to 75 universally expressed pneumococcal proteins associated with protection against colonisation. We measured serum IgG using a novel Luminex assay and cytokine responses from peripheral blood mononuclear cells following antigen stimulation. No individual IgG or cytokine marker correlated significantly with protection in univariate analysis. However, machine learning identified IgG responses to PdB, SP1069, and SP0899 as predictive of protection. MCP-1 responses to SP1069 and SP0899, and IL-17 production in response to SP0648-3 also correlated with protection. Elevated baseline IFN-γ, RANTES, and anti-protein IgG correlated with lower colonisation density. We highlight SP1069 and SP0899 as potential serotype-independent vaccine candidates and demonstrate the utility of machine learning to identify immune correlates of protection. Graphical Abstract
Authors 20
-
City St George's, University of London
Affiliation as printed
City St George's, University of London;
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
London School of Hygiene & Tropical Medicine
Affiliation as printed
London School of Hygeine and Tropical Medicine;
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
Murdoch Children's Research Institute
Affiliation as printed
Infection, Immunity and Global Health, Murdoch Childrens Research Institute, Melbourne;
-
Affiliation as printed
BioGrad Limited, Liverpool;
-
Affiliation as printed
Laboratório de Bacteriologia, Instituto Butantan;
-
Affiliation as printed
Laboratório de Bacteriologia, Instituto Butantan;
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
University of Liverpool · Liverpool School of Tropical Medicine
Affiliation as printed
Department of Clinical Sciences, Liverpool School of Tropical Medicine;
-
Affiliation as printed
Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo;
-
Centre for Inflammation Research · University of Edinburgh
Affiliation as printed
Centre for Inflammation Research, University of Edinburgh;
-
Boston Children's Hospital · Harvard University
Affiliation as printed
Boston Children's Hospital, Harvard Medical School;
-
University of Liverpool · Liverpool School of Tropical Medicine
Affiliation as printed
Department of Clinical Sciences, Liverpool School of Tropical Medicine;
-
Boston Children's Hospital · Harvard University
Affiliation as printed
Boston Children's Hospital, Harvard Medical School;
-
Simon P. Jochems Aachen
Leiden University · Leiden University Medical Center
Affiliation as printed
Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
-
Daniela Mulari Ferreira corresponding
Affiliation as printed
Oxford Vaccine Group, Department of Paediatrics, University of Oxford;
Cited by 0 stored of 0
No patents citing this paper on Lens.org (checked 2026-10-11).